SAITTA, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 4.217
EU - Europa 3.258
AS - Asia 2.203
SA - Sud America 777
AF - Africa 90
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.557
Nazione #
US - Stati Uniti d'America 4.139
SG - Singapore 948
BR - Brasile 699
IE - Irlanda 694
CN - Cina 618
SE - Svezia 559
IT - Italia 498
RU - Federazione Russa 426
HK - Hong Kong 269
DE - Germania 257
PL - Polonia 234
FI - Finlandia 148
VN - Vietnam 125
GB - Regno Unito 110
UA - Ucraina 99
IN - India 73
FR - Francia 67
BE - Belgio 37
MX - Messico 33
CA - Canada 32
AR - Argentina 30
NL - Olanda 28
ZA - Sudafrica 28
AT - Austria 27
BD - Bangladesh 27
CI - Costa d'Avorio 22
ID - Indonesia 19
CZ - Repubblica Ceca 18
TR - Turchia 18
JP - Giappone 16
PK - Pakistan 14
ES - Italia 13
IQ - Iraq 13
EC - Ecuador 12
MA - Marocco 12
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 9
EE - Estonia 8
EG - Egitto 8
PY - Paraguay 8
VE - Venezuela 8
JO - Giordania 7
NZ - Nuova Zelanda 7
CH - Svizzera 6
KE - Kenya 6
CO - Colombia 5
IL - Israele 5
KG - Kirghizistan 5
LV - Lettonia 5
UY - Uruguay 5
AL - Albania 4
GH - Ghana 4
OM - Oman 4
AU - Australia 3
BO - Bolivia 3
CL - Cile 3
JM - Giamaica 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
TN - Tunisia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
DZ - Algeria 2
GD - Grenada 2
GE - Georgia 2
IR - Iran 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GL - Groenlandia 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 10.554
Città #
Dallas 717
Dublin 694
Ashburn 602
Singapore 516
Chandler 513
Nyköping 333
Hong Kong 269
Messina 249
Beijing 240
Jacksonville 227
Warsaw 226
Moscow 125
The Dalles 121
Ann Arbor 120
Los Angeles 120
Dearborn 107
Munich 89
Princeton 84
Medford 79
São Paulo 68
New York 67
Cambridge 62
Des Moines 60
Boardman 56
Houston 51
Helsinki 44
Turku 42
Buffalo 41
Bremen 39
Brussels 37
Ho Chi Minh City 37
Jinan 34
Tianjin 32
Redondo Beach 31
Shenyang 26
Brasília 25
Hyderabad 25
Pune 25
Brooklyn 23
Abidjan 22
Nuremberg 22
Wilmington 22
Belo Horizonte 21
Frankfurt am Main 21
Hanoi 21
Rio de Janeiro 21
Catania 20
Nanjing 20
San Mateo 19
Boston 18
Dong Ket 18
Woodbridge 18
Lancaster 17
Rome 17
Santa Clara 17
Tokyo 16
Guangzhou 15
Haikou 15
Jakarta 15
Orem 15
Denver 14
Johannesburg 14
London 14
Vienna 14
Amsterdam 13
Avola 13
Chennai 13
Montreal 13
Zhengzhou 13
Düsseldorf 12
Hebei 12
Seattle 12
Atlanta 11
Haiphong 11
Hangzhou 11
Phoenix 11
Porto Alegre 11
Curitiba 10
Mexico City 10
Ningbo 10
Poplar 10
Stockholm 10
Taizhou 10
Brno 9
Campinas 9
Chicago 9
Falls Church 9
Lahore 9
Lappeenranta 9
Palermo 9
Ankara 8
Fuzhou 8
Rosolini 8
Cairo 7
Council Bluffs 7
Manchester 7
Olomouc 7
Sorocaba 7
Tashkent 7
Amman 6
Totale 7.053
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 199
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 195
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 192
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 192
Atrial fibrillation in patients with cirrhosis 180
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 176
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 173
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 161
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 159
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 158
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 158
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 155
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 153
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 151
Ateromasia carotidea e livelli lipidici in soggetti affetti da DM2: risultati di una analisi retrospettiva 145
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 145
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 144
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 143
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 143
ANTIOXIDANT CAPACITY OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCS) AND CIGARETTE SMOKING 142
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 138
Pulse wave velocity and augmentation index, but notintima-media thickness, are early indicators ofvascular damage in hypercholesterolemic children 138
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 136
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 136
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 132
Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number 129
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 126
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 125
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 123
Anatomic variations: a rare variant of formation of the portal vein 122
Erectile dysfunction in compensated liver cirrhosis 122
Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. 119
Circulating progenitor cells and the elderly: a seven-year observational study. 117
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population 115
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 115
Capacità antiossidante delle cellule progenitrici endoteliali ed abitudine al fumo di sigaretta 114
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 114
Obesity and liver cancer 114
Mitochondrial DNA is a target of HBV integration 113
Potenziali indicatori di longevità in una popolazione di anziani siciliani 112
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 110
879 CHOLANGIOPATHY AND HCC IN MDR3 DEFICIENCY 109
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 107
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 107
Circulating progenitor cells and high density lipoprotein levels in elderly 106
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 106
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. 105
The changing scenario of hepatocellular carcinoma in Italy: an update 105
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 104
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness 103
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 103
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 102
Olmesartan and atorvastatin are effective in improving circulating progenitor cells profile in hypertensive subjects 102
CIRCULATING PROGENITOR CELLS AND HIGH DENSITY LIPOPROTEIN LEVELS IN ELDERLY 99
XXI National Congress of the Italian Society for the Study of Arteriosclerosis (SISA) 21–24 November, Perugia, Italy 99
Pattern of macrovascular invasion in hepatocellular carcinoma 98
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients 96
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians. 95
Fever and rhomboid target lesion in decompensated cirrhosis 95
Identification of extracellular superoxide dismutase, EC-SOD, mutations in a Sicilian population 93
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 93
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 88
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 86
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1 86
Smoke exposure and circulating progenitor cells: Evidence for modulation of antioxidant enzymes and cell count 83
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 80
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 78
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals 78
Oxidative stress and flogosis: The role of endothelial progenitor cells in rheumathoid arthtritis 77
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 77
Monofocal hepatocellular carcinoma: How much does size matter? 76
PAF-AH gene polymorphisms and carotid atherosclerosis in sicilian hypercholesterolemic subjects 75
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography. 72
Arterial hypertension as a comorbidity of cirrhosis 68
The paraoxonase promoter polymorphism (-107)T > C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients 68
Occult hepatitis B virus and hepatocellular carcinoma. 68
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 66
Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy. 66
null 66
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. 66
Vit d deficiency, depletion of circulating endothelial progenitor cells and impaired arterial stiffness in patients with ra 66
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 65
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 65
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2 65
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 64
Treatment of the Hepatitis B Virus and Hepatitis C Virus Combined Infection: Still a Challenge for the Hepatologist. 64
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 63
Tissue Factor and Monocyte Chemoattractant Protein-1 expression in hypertensive subjects with normal or increased carotid intima-media thickness 63
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 63
Toll-like receptor 3 and interleukine 1b expression in circulating progenitor cells isolated from patients with rheumatoid arthritis 61
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 61
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 59
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 57
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. 54
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of “drug class change” 51
null 50
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 49
Occult hepatitis B virus infection: an update 47
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 45
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 44
Totale 10.441
Categoria #
all - tutte 38.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 49 46 50 26 96 30 36
2021/2022622 11 55 21 25 27 15 37 23 9 128 88 183
2022/20231.950 143 209 78 157 163 179 25 128 808 10 37 13
2023/2024495 37 81 27 40 33 111 3 27 2 49 22 63
2024/20252.544 30 71 76 155 162 130 95 455 591 161 248 370
2025/20263.347 426 628 624 499 652 518 0 0 0 0 0 0
Totale 10.816